Nesfatin-1 attenuates injury in a rat model of myocardial infarction by targeting autophagy, inflammation, and apoptosis

Arch Physiol Biochem. 2023 Feb;129(1):122-130. doi: 10.1080/13813455.2020.1802486. Epub 2020 Aug 7.

Abstract

Nesfatin-1 plays an important role in the modulation of heart performance. However, it remains unclear how nesfatin-1 contributes to cell survival in acute myocardial infarction (MI). A rat model of MI was established via ligation of left anterior descending coronary artery (LAD) for 30 min and 20 µg/kg concentration of nesfatin-1 was intraperitoneally infused prior to reperfusion. At 24 h after reperfusion, oxidative stress markers, the expression of caspase3, beclin-1, pro-inflammatory cytokines, and the mRNA levels of Bax and Bcl-2 were evaluated. Results showed that nesfatin-1 markedly restored GSH content and SOD activity as well as reduced MDA levels compared to only the MI group (p < .05). Likewise, nesfatin-1 contributed to cell survival by inhibiting autophagy and apoptosis markers such as caspase3 and Bax (p < .05). Collectively, these findings support the idea that nasfatin-1 can be used as a good candidate to treat MI by targeting oxidative stress, apoptosis, and autophagy.

Keywords: Myocardial infarction; apoptosis; autophagy; nesfatin-1; oxidative stress.

MeSH terms

  • Animals
  • Apoptosis*
  • Autophagy
  • Inflammation
  • Myocardial Infarction* / metabolism
  • Oxidative Stress
  • Rats
  • bcl-2-Associated X Protein / metabolism

Substances

  • bcl-2-Associated X Protein
  • NUCB2 protein, human